IBD: Ulcerative Colitis
Benefit and Risk Assessment Tool for IBD Treatments
[iframe_loader type=’iframe’ width=’100%’ height=’600′ frameborder=’0′ scrolling=’no’ src=’/wp-content/uploads/articulate_uploads/IBD-Benefits-and-Risk-Assesment-Tool4/story.html’]
This e-learning tool was made possible due to an unrestricted educational grant from Pfizer Canada
Related Articles
Date Written: 09-2020 *This information is intended for educational purposes and is not intended to replace recommendations that have been provided by your Physician and Health […]
At the start of 2020 the government announced that coverage was changing for people who take Remicade® (infliximab) for the treatment of Crohn’s disease or ulcerative […]
This empowering session reviewed the basics of IBD, outlined the benefits and risks of medications used to treat ulcerative colitis and Crohn’s disease and answered the […]